KELOWNA, BC – Lexaria Bioscience Corp, a global innovator in drug delivery platforms is pleased to announce final results from Human Pilot Study #5 (GLP-1-H25-5) (the “Study”), which compared oral… Read More
UBC researchers used AI to identify sex differences in diabetic retinopathy that could be essential for precision diagnostics and care. Sex differences could play a key role in how vision… Read More
Expanded FDA approval across multiple cervical cancer screening modalities supports clinical flexibility and provider choice MARLBOROUGH, Mass – Hologic, Inc. announced that its Aptima® HPV Assay received FDA approval for… Read More
First province in Canada to publicly reimburse this expanded indication of Jemperli, marking a significant milestone in access to treatment. This listing removes a key financial barrier for eligible Quebecers, enabling… Read More
Understanding how immune cells recognize one another is essential for developing better treatments for cancer, autoimmune disease, and inflammation. Many of the signals they use involve glycans, the complex sugars… Read More
